The supramolecular interaction between the pathogenic form of the prion protein and derivatives of the para-sulfonato-calix[n]arenes has been demonstrated and two putative binding sites determined; this interaction leads to an amplification of the Western Blot immunological detection of the prion protein by the SAF84 antibody.
No takes yet. Share an insight, caveat, or question.
Coleman et al. (2007) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: